STAPHYLOCIDE : Delivering Antibiotic Resistance Gene Silencing - - PowerPoint PPT Presentation

staphylocide
SMART_READER_LITE
LIVE PREVIEW

STAPHYLOCIDE : Delivering Antibiotic Resistance Gene Silencing - - PowerPoint PPT Presentation

STAPHYLOCIDE : Delivering Antibiotic Resistance Gene Silencing Mechanisms to a MRSA Population using Bacterial Conjugation "The problem is so serious that it threatens the achievements of modern medicine. - World Health Organization,


slide-1
SLIDE 1

STAPHYLOCIDE:

Delivering Antibiotic Resistance Gene Silencing Mechanisms to a MRSA Population using Bacterial Conjugation

slide-2
SLIDE 2

"The problem is so serious that it threatens the achievements of modern medicine. ”

  • World Health Organization, Antimicrobial Resistance:

Global Report on Surveillance 2014

slide-3
SLIDE 3

80 461

slide-4
SLIDE 4

11 285

slide-5
SLIDE 5 Infectious Diseases Society of America Clin Infect Dis. 2011; 52:S397-S428 Adapted from: Data collected from hospital intensive care units that participate in the National Nosocomial Infections Surveillance System of the Centers for Disease Control.

MRSA Cases by Year

16 14 12 7 4 2

2 4 6 8 10 12 14 16 18

Number of new antimicrobial agents approved by the FDA for humans Cases in Thousands

slide-6
SLIDE 6

MRSA resistance in a nutshell

Penicillin PBP Chromosome Cell Wall

Staphylococcus aureus

slide-7
SLIDE 7

MRSA resistance in a nutshell

Methicillin Resistant Staphylococcus aureus

mecA gene Penicillin PBP2A Chromosome Cell Wall

slide-8
SLIDE 8 mecA mRNA Transcription Translation PBP2 A mecA mRNA Transcription Translation PBP2 A mecA mRNA Transcription Translation PBP2 A

MRSA STAPHYLOCIDE

slide-9
SLIDE 9

IMPROVING THE REGISTRY

slide-10
SLIDE 10

9

Promoters

  • 1. sarA P1 – Strong constitutive
  • 2. Xylose inducible promoter construct

Ribosome Binding Sites

  • 1. sodA RBS
  • 2. Optimized TIR RBS

Terminators

  • 1. sarA rho-independent

Staphylococcal Parts

Selection Markers

  • 1. ermM – Erythromycin resistance
  • 2. aadD – Kanamycin resistance
  • 3. spC – Spectinomycin resistance

Origin of Replication

  • 1. pSK41
  • S. aureus
  • Theta Replictation
  • Low copy

Reporters

  • DsRed
  • YFP
slide-11
SLIDE 11

10

  • S. epidermidis (ATCC 12228)
  • Level 1 organism
  • Native to human microbiota
  • Able to conjugate with S. aureus
  • No endogenous CRISPR system unlike other
  • S. epidermidis strains

Staphylococcal Strain

slide-12
SLIDE 12

11

Reporter Gene: DsRed

  • E. coli
  • S. epidermidis
  • ve control
slide-13
SLIDE 13

12

  • E. coli-Staphylococcus Shuttle Vector

BBa_K1323017

ErmR

  • riVE. coli

CmR

  • riVS.aureus

P S RFP Expression Cassette (BBa_J04450) VF2 VR

Improved pSB1C3 by making it more versatile:

pSB1C3 parts Parts we introduced

slide-14
SLIDE 14

13

Shuttle Vector: Antibiotic Resistance

  • Stably maintained in
  • S. epidermidis
  • Confers erythromycin

resistance

slide-15
SLIDE 15

DELIVER SILENCE TRANSLATE

slide-16
SLIDE 16

SILENCE

Design Translation Transcription

slide-17
SLIDE 17

16

Silence

YFP mRNA Transcription Translation YFP

slide-18
SLIDE 18

17

Silence: CRISPRi

dCas9-sgRNA complex blocks RNA polymerase

slide-19
SLIDE 19

18

Silence: CRISPRi Network

slide-20
SLIDE 20

19

Silence: CRISPRi Results

slide-21
SLIDE 21

20

Silence: CRISPRi Sensitivity

  • Sensitive to mRNA

degradation rate Therefore…

  • Targeting of

translation will improve silencing!

slide-22
SLIDE 22

21

Silence: RNAi

sRNA-Hfq complex blocks ribosome

slide-23
SLIDE 23

22

Silence: RNAi Network

slide-24
SLIDE 24

23

Silence: RNAi Results

slide-25
SLIDE 25

24

Silence: Design

YFP mRNA Transcription Translation YFP

CRISPRi

dCas9-sgRNA Complex

slide-26
SLIDE 26

25

pSB1A3

AmpR

  • riVE.coli

ErmR

  • riVS. aureus
TT

sgRNA

Pconst

Silence: CRISPRi

dCas9 xylose XylR

TT
slide-27
SLIDE 27

26

Silence: Design

YFP mRNA Transcription Translation YFP

RNAi CRISPRi

dCas9-sgRNA Complex Hfq-sRNA Complex

slide-28
SLIDE 28

27

pSB1A3

AmpR

  • riVE.coli

ErmR

  • riVS. aureus
TT

sRNA

Pconst

Silence: RNAi

Hfq xylose

TT

xylR

slide-29
SLIDE 29

28

Silence: RNAi Design

YFP CDS Scar RBS YFP mRNA 5’ 3’ …

sRNA 1 sRNA 2 sRNA 3

slide-30
SLIDE 30

29

Co- Transform

Silence: RNAi Preliminary Tests

pSB3K3

  • E. coli DH5α

Measure fluorescence

pSB1A3

slide-31
SLIDE 31

30

Silence: RNAi Preliminary Test

YFP Alone Control sRNA1 sRNA2 sRNA3 RFU/OD600

slide-32
SLIDE 32

31

  • Characterize silencing systems in S. epidermidis
  • Integrate yfp into S. epidermidis genome
  • Incorporate the mecA gene

regulation

Silence: Future Directions

slide-33
SLIDE 33

DELIVER

Modeling Lab Design

slide-34
SLIDE 34

33

Conjugation in Staphylococcus

Solid Surface

Recipient Donor

slide-35
SLIDE 35

34

Deliver: Conjugation

Advantages:

  • Large carrying capacity
  • Independently propagates
  • Opportunity to contribute

to an underdeveloped area of research Disadvantage:

  • Not efficient
slide-36
SLIDE 36

35

Conjugation Parts: pGO1

pGO1: S. aureus conjugational plasmid

  • riT-nes: BBa_K1323003
  • riT
nes RBS TT

2.2 kb

trs Region: Still in progress

trs: 13.5 kb

slide-37
SLIDE 37

36

Conjugation Test Construct

pSBS1A3

ErmR

AmpR

  • riVE.coli

P

DsRed TT RBS
  • riVS. aureus
nes TT RBS
  • riT
trs genes

S Recipients

Donor Transconjugants Filter Mating Assays

slide-38
SLIDE 38

37

Deliver: Modeling

Challenge: Modeling conjugation between cells spread across a lab plate or a patient’s skin

slide-39
SLIDE 39

38

Deliver: Modeling

Two novel models: Partial Differential Equation (PDE) is deterministic and computationally efficient Agent-Based Approach is stochastic and considers the spatial relationships between individual cells Output: time needed for silencing to spread

slide-40
SLIDE 40

39

Deliver: Agent Based Model

Staphylococcus conjugation rate Susceptible Staphylococcus MRSA Sufficient conjugation rate t = 0 h t = 0 h

slide-41
SLIDE 41

40

Deliver: Agent Based Model

Staphylococcus conjugation rate Susceptible Staphylococcus MRSA Sufficient conjugation rate t = 6 h t = 6 h

slide-42
SLIDE 42

41

Deliver: Agent Based Model

Staphylococcus conjugation rate Susceptible Staphylococcus MRSA Sufficient conjugation rate t = 12 h t = 12 h

slide-43
SLIDE 43

42

Deliver: Agent Based Model

Staphylococcus conjugation rate Susceptible Staphylococcus MRSA Sufficient conjugation rate t = 24 h t = 24 h

slide-44
SLIDE 44

43

Deliver: Agent Based Results

slide-45
SLIDE 45

44

Deliver: PDE Model Results

slide-46
SLIDE 46

45

Deliver: Future Uses of Model

+

Find igem-waterloo on GitHub!

slide-47
SLIDE 47

46

  • Improve conjugation efficiency with error prone

PCR mutagenesis and selective mating assays

Deliver: Future Directions

  • Test conjugational efficiency in
  • S. epidermidis
slide-48
SLIDE 48

TRANSLATE

Adaptability Safety Market Viability

slide-49
SLIDE 49

48

Translate: Commercialization

STAPHYLOCIDE Plasmid

Conjugation Parts

slide-50
SLIDE 50

49

Translate: Commercialization

slide-51
SLIDE 51

50

Translate: Commercialization

slide-52
SLIDE 52

51

Translate: Commercialization

β-Lactam Antibiotic

slide-53
SLIDE 53

52

Translate: Commercialization

β-Lactam Antibiotic

slide-54
SLIDE 54

53

Translate: Adaptability

slide-55
SLIDE 55

DELIVER SILENCE TRANSLATE

slide-56
SLIDE 56

55

Submitted 19 BioBricks, 8 characterized

Improved BioBrick backbone to develop shuttle vector

Produced and validated several models of the silencing and delivery systems

Explored scalability of project

Collaborated on uOttawa iGEM & Virginia Tech project and assisted with oGEM

Accomplishments

slide-57
SLIDE 57

56

Accomplishments: Outreach

High School Enrichment Program

Science Club

Lab Skills Video Series

Sir John A. Macdonald Secondary School

slide-58
SLIDE 58

57

Acknowledgements

  • Dr. Marc

Aucoin

  • Dr. Brian

Ingalls

  • Dr. Matthew

Scott

  • Dr. Trevor

Charles

  • Dr. Barbara

Moffat

  • Dr. Andrew

Doxey

slide-59
SLIDE 59

Questions?

slide-60
SLIDE 60

59

Bayer, M. G., Heinrichs, J. H., & Cheung, A. L. (1996). The molecular architecture of the sar locus in Staphylococcus aureus. Journal of Bacteriology, 178(15): 4563-70 Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. a. (2013). Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas
  • system. Nucleic Acids Research, 41(15): 7429–3
Bose, J. L., Fey, P. D., & Bayles, K. W. (2013). Genetic Tools to Enhance the Study of Gene Function and Regulation in Staphylococcus aureus. Applied Environmental Microbiology, 79(7): 2218- 2224. Caryl, J. A. and O’Neill, A. J. (2009). Complete nucleotide sequence of pGO1, the prototype conjugative plasmid from the staphylococci. Plasmid, 62: 35-38 Cirino, P. C., Mayer, K. M., and Umeno, D. (2002). Chapter 1: Generating Mutant Libraries Using Error-Prone PCR, Methods in Molecular Biology, vol. 231. New Jersey: Humana Press Inc. Climo, M. W., Sharma, V. K., and Archer, G. L. (1996). Identification and Characterization of the Origin of Conjugative Transfer (oriT) and a Gene (nes) Encoding a Single-Stranded Endonuclease
  • n the Staphylococcal Plasmid pGO1. Journal of Bacteriology, 178 (16): 4975-83
Fey, P. D. (2014). Staphylococcus epidermidis: methods and protocols. New York: Springer Science + Business Media, LLC. Horstmann, N., Orans, J., Valentin-Hansen, P., Shelburne III, S. A., & Brennan, R. G. (2012). Structural mechanism of Staphylococcus aureus Hfq binding to an RNA A-tract. Nucleic Acids Research, 1-13. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., and Charpentier, E. (2012). A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science, 337: 816-821. Katze, M. J., He, Y., and Gale, M. (2002). Viruses and Interferon: A Fight for Supremacy. Nature Reviews, 2: 675-687. Larson, M. H., Gilbert, L. A., Wang, X., Lim, W. A., Weissman, J. S., and Qi, L. S. (2013). Nature Protocols, 8 (11): 2180-2196.

References

slide-61
SLIDE 61

60

Malone, C. L., Boles, B. R., Lauderdale, K. J., Thoendel, M., Kavanaugh, J. S., & Horswill, A. R. (2009). Fluorescent Reporters for Staphylococcus aureus. Journal of Microbiological Methods, 77(3): 251-260. Qi, L. S., Larson, M. H., Gilbert, L. a, Doudna, J. a, Weissman, J. S., Arkin, A. P., & Lim, W. a. (2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene
  • expression. Cell, 152(5): 1173–83.
Yoo, S. M., Na, D., & Lee, S. Y. (2013). Design and use of synthetic regulatory small RNAs to control gene expression in Escherichia coli. Nature Protocol, 8 (9): 1694-1707. Zhang, Y-Q. (2003). Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Molecular Microbiology, 49(6): 1577-1593. Zhao, H. (2004). Staggered Extension Process In Vitro DNA Recombination, Methods in Enzymology, vol. 388, 42-49.

References